在CKD相关的骨质疏松症中应用特里巴提德:疗效和安全性考虑
1Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, NO.182, Chunhui Road, Longmatan District, Luzhou, 646000, Sichuan Province, People's Republic of China. luolin311@126.com.
International urology and nephrology
|June 4, 2025
概括
在慢性脏病 (CKD) 中,特里巴拉提德对骨质疏松症具有可变的疗效. 一些患者的骨密度有所改善,但在晚期CKD阶段,阿伦德罗纳酸对骨折预防更好.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 骨质疏松症是慢性病 (CKD) 的重要并发症.
- 在CKD相关的骨质疏松症治疗teriparatide的疗效和安全性是有争议的.
- 响应的变化可能与CKD阶段和骨周转状态有关.
研究的目的:
- 分析治疗慢性脏病 (CKD) 患者骨质疏松症的特里巴提德的疗效和安全性.
- 为了比较teriparatide与其他治疗方法,如在不同CKD阶段的alendronate.
- 确定影响特里巴胺反应的因素和潜在的风险,如高血症.
主要方法:
- 对CKD患者的teriparatide和骨质疏松症现有研究的审查.
- 对骨矿物质密度变化和骨折预防率的分析.
- 评估骨循环标志物和酸代谢.
主要成果:
- 特里巴提提德改善了移植患者的骨密度,骨周转率较低.
- 阿伦德罗纳酸在预防CKD3b/4.4阶段骨折方面显示出更大的有效性.
- 在骨循环标记物中观察到不一致的反应,特别是在晚期CKD中.
- 发现高血症的风险为22.2%,与酸代谢和副甲状腺功能有关.
结论:
- 在CKD相关的骨质疏松症中,teriparatide的疗效是可变的,并且取决于CKD阶段和骨周转.
- 阿伦德罗纳特在晚期CKD阶段的骨折预防方面可能更有效.
- 对于个性化治疗策略,需要进一步研究骨活检和多中心研究.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
01:17Hormones and Bone Tissue
3.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
01:24Chronic Kidney Disease II: Clinical Manifestations
559
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
559
01:40Bone Remodeling
40.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
01:31Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K